[Rheolytic thrombectomy with AngioJet catheter during transluminal coronary revascularization in patients with acute...

Area of Science:

• Interventional Cardiology
• Cardiovascular Medicine
• Medical Device Technology

Background:

• Balloon angioplasty and stenting are standard treatments for acute myocardial infarction (MI).
• Thrombus presence during MI interventions can lead to reduced coronary flow and distal embolization.
• Mechanical thrombectomy devices are explored as adjunctive therapies to mitigate these complications.

Purpose of the Study:

• To evaluate the safety and efficacy of AngioJet rheolytic thrombectomy in patients with acute MI and significant thrombus.
• To assess immediate angiographic, in-hospital, and 30-day clinical outcomes following rheolytic thrombectomy and definitive treatment.

Main Methods:

• A study of 185 patients with acute MI and angiographically evident thrombus.
• Patients underwent AngioJet rheolytic thrombectomy followed by definitive treatment (stenting or balloon angioplasty).
• Outcomes included procedural success, thrombus reduction, final coronary flow (TIMI), complications, and clinical events.

Main Results:

• Procedural success rate was 97%, with 89% achieving final TIMI 3 flow.
• AngioJet significantly reduced thrombus area (mean 69.6 mm² to 17.3 mm²).
• Clinical success was 88%, with 7.0% in-hospital mortality and no major adverse events at 30-day follow-up.

Conclusions:

• Rheolytic thrombectomy with AngioJet is a safe and effective adjunctive therapy for acute MI patients with thrombus.
• This approach facilitates immediate definitive treatment of complex lesions.
• It leads to significant thrombus burden reduction and favorable clinical outcomes.